MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, CSTL made $344,229K in revenue. -$24,158K in net income. Net profit margin of -7.02%.

Income Overview

Revenue
$344,229K
Net Income
-$24,158K
Net Profit Margin
-7.02%
EPS
-$0.83
Unit: Thousand (K) dollars
Revenue Breakdown
    • Dermatologic
    • Non Dermatologic

Income Statement
2025-12-31
2024-12-31
Net revenues
344,229 332,069
Cost of sales (exclusive of amortization of acquired intangible assets)
71,028 60,205
Research and development
51,850 52,041
Selling, general and administrative
229,323 200,047
Amortization of acquired intangible assets
34,838 11,106
Total operating expenses, net
387,039 323,399
Operating (loss) income
-42,810 8,670
Interest income
11,772 12,916
Net gains on equity securities
1,466 -
Interest expense
86 577
Changes in fair value of trading securities
-555
Other income
144 -
(loss) income before income taxes
-29,514 21,564
Income tax (benefit) expense
-5,356 3,319
Net (loss) income
-24,158 18,245
Basic EPS
-0.83 0.66
Diluted EPS
-0.83 0.62
Basic Average Shares
28,986,000 27,776,000
Diluted Average Shares
28,986,000 29,255,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net (loss) income-$24,158K (-232.41%↓ Y/Y)Income tax (benefit)expense-$5,356K (-261.37%↓ Y/Y)(loss) income beforeincome taxes-$29,514K (-236.87%↓ Y/Y)Interest income$11,772K (-8.86%↓ Y/Y)Net gains on equitysecurities$1,466K Other income$144K Dermatologic$216,369K (-15.81%↓ Y/Y)Non Dermatologic$127,860K (70.31%↑ Y/Y)Operating (loss) income-$42,810K (-593.77%↓ Y/Y)Net revenues$344,229K (3.66%↑ Y/Y)Interest expense$86K (-85.10%↓ Y/Y)Total operatingexpenses, net$387,039K (19.68%↑ Y/Y)Selling, general andadministrative$229,323K (14.63%↑ Y/Y)Cost of sales(exclusive of amortization...$71,028K (17.98%↑ Y/Y)Research and development$51,850K (-0.37%↓ Y/Y)Amortization of acquiredintangible assets$34,838K (213.69%↑ Y/Y)

CASTLE BIOSCIENCES INC (CSTL)

CASTLE BIOSCIENCES INC (CSTL)